Tim Hauwermeiren is the founder of argenx. argenx has raised $4B in total funding. Latest round: IPO. Based in Ghent, Belgium.
Tim van Hauwermeiren is the co-founder and CEO of argenx, a biotechnology company focused on developing novel treatments for immune-mediated diseases. He led the company through early challenges, including a near-bankruptcy situation, and later oversaw its growth to raising nearly $4 billion on the Nasdaq.
Full founder directory · Investor directory · Company funding database · Fundraising library